Nicox has announced an agreement with GHO Capital, a London-based specialist investor in health care, to transfer its commercial operations to a new private company focusing on the commercialization of ophthalmic products in Europe. Under the terms of the transaction, which awaits completion, Nicox will assign rights to its European ...

Buying a membership today will give you:
To continue reading this article register now.